Search results for "Survival"

showing 10 items of 3291 documents

Pancreatic and periampullary tumours: morbidity, mortality, functional results, and long-term survival

2009

Abstract Aims To evaluate postoperative morbidity and mortality, pancreatic function and long-term survival in patients with surgically treated pancreatic or periampullar tumours. Patients and methods Cohort study including 160 patients consecutively operated on: 80 pancreaticoduodenectomies (PD), 30 distal pancreatectomies (DP), 7 total pancreatectomies, 4 central pancreatic resections, and 3 ampullectomies. The tumour was not resected in 36 patients. Pancreatic function was evaluated by oral glucose tolerance test, faecal fat excretion, and elastase. Results Resectability rate was 77.5%. In resected patients (n = 124), 38.7% had complications with a pancreatic fistula rate of 6.4% and a m…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMortality rateGeneral EngineeringAmpulla of VaterPerioperativePancreaticoduodenectomymedicine.diseaseGastroenterologymedicine.anatomical_structurePancreatic fistulaInternal medicinePancreatic cancermedicinebusinessSurvival rateCohort studyCirugía Española (English Edition)
researchProduct

Prognostische Bedeutung des e-Cadherin beim papillären Schilddrüsencarcinom

1998

The prognostic significance of e-cadherin in papillary thyroid carcinoma was evaluated in a retrospective study. From September 1985 to December 1996, 113 patients underwent surgery for papillary thyroid carcinoma. Seventy-eight formalin-fixed, paraffin-embedded tissue samples were available for immunohistochemical analysis of e-cadherin expression. In 74 of these 78 patients the postoperative course is known for 2 months to 35.2 years (median 3.6 years, mean: 4.9 +/- 4.8 years). Reduced or negative e-cadherin expression ( 20%. Statistical analysis revealed e-cadherin expression ( 20%), synchronous distant metastasis (M0/pM1, cM1) and radicality of resection (R0/R1, 2) as significant risk f…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentThyroidectomyRetrospective cohort studymedicine.diseaseGastroenterologyThyroid carcinomaCardiothoracic surgeryInternal medicinemedicineCarcinomaImmunohistochemistrySurgerybusinessSurvival rateAbdominal surgeryDer Chirurg
researchProduct

Kryotherapie primärer und sekundärer Lebertumoren

2002

AIMS We assessed the morbidity, mortality and efficacy of cryotherapy for primary and secondary malignant liver tumours in a prospective case control study. METHODS Since 1996 we performed 77 cryosurgical procedures on 71 patients. 6 patients had hepatocellular carcinoma, the remainders metastases, mainly of colorectal origin (n = 49). Cryotherapy was used when a complete tumour resection was not feasible, but complete tumour destruction by cryotherapy seemed possible. Mean follow-up was 21 months. RESULTS The mean number of lesions per patient was 2.6 (1-10) with a mean maximum diameter of 3.7 cm (1-11). In 36 of 71 patients cryotherapy was used in combination with liver resection. Morbidi…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentTumor resectionCase-control studyCryotherapyLiver tumoursmedicine.diseaseSurgeryResectionMaximum diameterHepatocellular carcinomamedicineSurgerybusinessSurvival rateZentralblatt für Chirurgie
researchProduct

Comparison of Standard Cardiopulmonary Resuscitation Versus the Combination of Active Compression-Decompression Cardiopulmonary Resuscitation and an …

2003

Background— Active compression-decompression (ACD) CPR combined with an inspiratory impedance threshold device (ITD) improves vital organ blood flow during cardiac arrest. This study compared survival rates with ACD+ITD CPR versus standard manual CPR (S-CPR). Methods and Results— A prospective, controlled trial was performed in Mainz, Germany, in which a 2-tiered emergency response included early defibrillation. Patients with out-of-hospital arrest of presumed cardiac pathogenesis were sequentially randomized to ACD+ITD CPR or S-CPR by the advanced life support team after intubation. Rescuers learned which method of CPR to use at the start of each work shift. The primary end point was 1-ho…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmenteducationImpedance threshold deviceReturn of spontaneous circulationmedicine.diseaseAdvanced life supportSurgeryPhysiology (medical)AnesthesiaVentricular fibrillationmedicineIntubationCardiopulmonary resuscitationCardiology and Cardiovascular MedicineProspective cohort studybusinessSurvival ratehealth care economics and organizationspsychological phenomena and processesCirculation
researchProduct

Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide

2021

Abstract Treatment of hepatocellular carcinoma (HCC) depends on the stage of disease. In the Western Hemisphere, the Barcelona Clinic Liver Cancer classification (BCLC) is the preferred staging system. Approximately one-third of patients initially present with intermediate-stage disease. For these patients, transarterial chemoembolization (TACE) is the treatment of choice. However, the intermediate-stage comprises a heterogeneous subgroup of patients with considerable differences in tumor burden and liver function. In addition, differences in individual factors that are not captured by the BCLC framework, such as the tumor growth pattern, degree of hypervascularity, and vascular supply, com…

medicine.medical_specialtybusiness.industrypractical step-by-step guideReviewhepatocellular carcinomatransarterial chemoembolizationHypervascularityDiseasemedicine.disease03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisHepatocellular carcinomaMedicine030211 gastroenterology & hepatologyTumor growthLiver functiontreatment decision supportStage (cooking)businessLiver cancerIntensive care medicinesurvival predictionStaging systemJournal of Hepatocellular Carcinoma
researchProduct

The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma

2021

Incidence and mortality of intrahepatic cholangiocarcinoma (iCCA) have been increasing continuously. Recent studies suggest that the combination of palliative chemotherapy (pCTX) and transarterial chemoembolization (TACE) improves overall survival (OS). This study aimed to evaluate the outcome of patients treated with TACE and pCTX in unresectable iCCA at our tertiary care center. A group of 14 patients was treated with both pCTX and TACE. The non-randomized control group of 59 patients received pCTX alone. Patients received a median of two pCTX lines in both groups. Those treated with TACE underwent a median number of 3.5 sessions. Median OS from the time of unresectability was 26.2 months…

medicine.medical_specialtycombined modality therapymedicine.medical_treatmentchemotherapyGastroenterologysurvivalArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineCombined Modality TherapyStage (cooking)chemoembolizationIntrahepatic CholangiocarcinomaChemotherapyPerformance statusbusiness.industryIncidence (epidemiology)RGeneral MedicinePalliative chemotherapy030220 oncology & carcinogenesisPropensity score matchingMedicine030211 gastroenterology & hepatologybusinesscholangiocarcinomaJournal of Clinical Medicine
researchProduct

Rapid Steroid Withdrawal after Renal Transplantation Reduces Mortality: Five Year Follow-Up of a Randomized Controlled Trial (Harmony Study) Confirms…

2021

Background: We previously reported excellent efficacy and improved safety aspects of rapid steroid withdrawal (RSWD) in the randomized controlled one year “Harmony” trial, in which 587 predominantly deceased-donor kidney transplant recipients were randomized either to basiliximab or rabbit ATG induction therapy and compared to standard immunosuppressive therapy consisting of basiliximab, low tacrolimus once daily, mycophenolate mofetil, and corticosteroids. Methods: Following the end of the original one-year study period, patients were asked to participate in the observational follow-up (FU) study examining most of the end points of the original study. Hereby, de novo incidences between yea…

medicine.medical_specialtyeducation.field_of_studyBasiliximabbusiness.industryHazard ratioPopulationTacrolimuslaw.inventionTransplantationRandomized controlled triallawInternal medicinemedicineObservational studybusinesseducationSurvival ratemedicine.drugSSRN Electronic Journal
researchProduct

Survival of patients with gastric lymphoma in Germany and in the United States

2015

Background and Aim This study aims to examine survival for gastric lymphomas and its main subtypes, mucosa-associated lymphoid tissue lymphoma (MALT), and diffuse large B-cell lymphoma (DLBCL), in Germany and in the United States. Methods Data for patients diagnosed in 1997–2010 were used from 10 population-based German cancer registries and compared to the data from the US Surveillance, Epidemiology and End Results (SEER) 13 registries database. Patients age 15–74 diagnosed with gastric lymphomas were included in the analysis. Period analysis and modeled period analysis were used to estimate 5-year and 10-year relative survival (RS) in 2002–2010 and survival trends from 2002–2004 to 2008–2…

medicine.medical_specialtyeducation.field_of_studyHepatologyRelative survivalbusiness.industryGastric lymphomaPopulationGastroenterologymedicine.diseaseGastroenterologySurgeryCancer registryLymphomaimmune system diseaseshemic and lymphatic diseasesInternal medicineMedicinebusinesseducationMucosa-associated lymphoid tissueDiffuse large B-cell lymphomaSurvival rateJournal of Gastroenterology and Hepatology
researchProduct

Atteinte de la Muscularis Mucosae dans les tumeurs urothéliales T1 de vessie : facteur pronostique de progression après immunothérapie par BCG

2012

OBJECTIVES: To study the prognostic impact of muscularis mucosae (MM) invasion for pT1 bladder cancer treated by transurethral resection (TUR) and adjuvant Bacille Calmette-Guerin (BCG) intravesical immunotherapy. METHODS: Sixty-six patients treated by BCG intravesical instillations were substaged into pT1a and pT1b, regarding Muscularis Mucosae invasion. Tumor grade, associated carcinoma in situ (CIS), multifocality, tumoral size up to 3cm, BCG maintenance were noted. With a mean follow-up of 50.5±38 months, we studied recurrence, progression, overall and specific survival. Cox's model method was used for multivariate analysis. RESULTS: Tumor recurrence was observed in 30±7% and 43±10% (P=…

medicine.medical_specialtyeducation.field_of_studyPathologyMuscularis mucosaeBladder cancerbusiness.industryUrologymedicine.medical_treatmentCarcinoma in situPopulation030232 urology & nephrologyImmunotherapymedicine.diseaseGastroenterology3. Good healthCystectomy03 medical and health sciences0302 clinical medicineTumor progression030220 oncology & carcinogenesisInternal medicinemedicineProgression-free survivaleducationbusinessProgrès en Urologie
researchProduct

Population‐based study of the treatment and prognosis of carcinoma of the rectum

1997

Background Few population-based studies address the issue of treatment of carcinoma of the rectum (15 cm or less from the anal vcrge) both from surgical and epidemiological aspects. Methods Some 827 patients were analysed in the cancer registry of the Cote-d'Or (Burgundy, France) from 1976 to 1990 (493 931 inhabitants). Results Resection for cure increased from 57.2 per cent before 1981 to 77.0 per cent after 1985 (P <11.001), and the proportion of Dukes A and B cascs from 35.8 to 52.5 per cent (P< 0.001). Among patients resected for cure, continence-preserving resections were performed more frequently during the 1986-1990 period (48.0 per cent) than during the two previous 5-year periods (…

medicine.medical_specialtyeducation.field_of_studyRelative survivalbusiness.industryPopulationRectummedicine.diseaseColorectal surgeryCancer registrySurgerymedicine.anatomical_structureCarcinomaMedicineFecal incontinenceSurgerymedicine.symptombusinesseducationSurvival analysisBJS
researchProduct